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TGFβ-induced osteogenic potential 
of human amniotic fluid stem cells 
via CD73-generated adenosine 
production
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Anna L. David2 & Pascale V. Guillot  2
The human amniotic fluid stem cell (hAFSC) population consists of two morphologically distinct 
subtypes, spindle-shaped and round-shaped cells (SS-hAFSCs and RS-hAFSCs). Whilst SS-hAFSCs are 
routinely expanded in mesenchymal-type (MT) conditions, we previously showed that they acquire 
broader differentiation potential when cultured under embryonic-type (ET) conditions. However, the 
effects of culture conditions on RS-hAFSCs have not been determined. Here, we show that culturing 
RS-hAFSCs under ET conditions confers faster proliferation and enhances the efficiency of osteogenic 
differentiation of the cells. We show that this occurs via TGFβ-induced activation of CD73 and the 
associated increase in the generation of extracellular adenosine. Our data demonstrate that culture 
conditions are decisive for the expansion of hAFSCs and that TGFβ present in ET conditions causes 
the phenotype of RS-hAFSCs to revert to an earlier state of stemness. Cultivating RS-hAFSCs in ET 
conditions with TGFβ may therefore increase their therapeutic potential for clinical applications.
Human amniotic stem cells (hAFSCs) hold great therapeutic potential in regenerative medicine because they can 
be isolated from mid-trimester and term amniotic fluid samples without ethical restrictions, and are developmen-
tally more primitive than adult stem cells1–3.
The hAFSC population comprises two subpopulations of plastic-adherent multipotent cells that are mor-
phologically distinct, i.e. fast-growing spindle-shaped cells (SS-hAFSCs) and slow-growing round-shaped cells 
(RS-hAFSCs)4, 5. Populations of plastic-adherent multipotent spindle-shaped and round-shaped (also referred 
to as flat-shaped) stem cells have already been described in umbilical cord tissue (UC)6. Like SS-hAFSCs, 
UC-derived spindle-shaped stem cells only constitute a minority of cells, whilst round-shaped cells are present 
in greater proportion6.
SS-hAFSCs are routinely isolated and expanded under mesenchymal-type (MT) conditions, i.e. either in 
Dulbecco’s Modified Eagle’s Medium (DMEM), α-minimum essential medium (α-MEM) or Chang medium B 
and C supplemented with 5–15% fetal bovine serum (FBS), designed to sustain the phenotype of adult mesenchy-
mal stem cells (MSCs)3, 5, 7. However, hAFSCs have been described as having a privileged intermediate phenotype 
between embryonic stem cells (ESCs) and adult MSCs. This is because they express the standard MSC markers 
and can be expanded to large numbers without the need for feeder cell layers8, 9, but they also exhibit broader 
differentiation potential, longer telomeres and more active telomerase activity than adult MSCs10, 11.
We previously showed that switching the culture conditions of SS-hAFSCs from MT conditions to con-
ditions used to maintain the pluripotent state of ESCs (ET) induced important phenotypic phenotype changes 
such as greater proliferation kinetics, reactivation of some markers associated with pluripotency and the ability 
to form embryonic bodies10, 12. However, RS-hAFSCs, which are routinely expanded in MT conditions, have been 
described as slow-growing cells with limited differentiation potential compared to their SS-hAFSC counterparts 4, 5.
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Here, we investigated whether culturing RS-hAFSCs in ET culture conditions, either from the time of isola-
tion from the amniotic fluid samples or following initial expansion in MT culture conditions, would positively 
impact on the phenotype of the cells. We show that ET culture conditions stimulate the expansion kinetics of 
RS-hAFSCs and promote the efficiency of osteogenic differentiation of the cells via transforming growth factor 
(TGF)β-induced activation of CD73 and the associated increase in adenosine production.
Results
ET culture conditions reduced the cell size and increased growth kinetics and alkaline phos-
phatase expression in RS-hAFSCs. To assess whether the culture conditions of RS-hAFSCs affects their 
phenotype and determine the optimal culture conditions for in vitro expansion, we isolated and subsequently 
maintained RS-hAFSCs either in mesenchyme type (MT) conditions or human embryonic stem cells (ET) con-
ditions on Matrigel-coated plates in Nutristem media. We also isolated and expanded RS-hAFSCs in MT or ET 
culture conditions until the cells reached passage 5, at which time the cells expanded in MT conditions were 
switched to ET conditions (MT-ET) and vice versa (ET-MT) for another 5 passages (Fig. 1A). Three different 
hAFSC samples were analysed throughout the study. RS-hAFSCs exhibited a round-shaped morphology under 
each culture conditions (Fig. 1B), although the size of cells cultivated in ET conditions (ET and MT-ET condi-
tions) was smaller than the size of the cells cultivated in MT conditions (Fig. 1C).
RS-hAFSCs expanded wholly or subsequently in ET conditions (ET or MT-ET) showed higher growth kinet-
ics than cells expanded in wholly or subsequently in MT conditions (MT or ET-MT), as evidenced by higher 
cumulative population doubling (CPD) (7.6 ± 0.8 and 7.5 ± 0.8 vs. 12.6 ± 1.2 and 13.2 ± 1.3, p < 0.001) over the 
16 days of analysis (Fig. 1D). These results indicate that growing RS-hAFSCs in ET conditions favors their expan-
sion and survival.
In non-pluripotent stem cells, alkaline phosphatase (AP) is associated with proliferation13, and is a mark 
of osteogenic progenitors14, 15. We found that AP was not expressed in RS-hAFSCs cultured wholly or subse-
quently in MT conditions (MT or ET-MT), but culturing the cells wholly or subsequently in ET conditions (ET or 
MT-ET) induced AP expression, even when the cells have been isolated and initially expanded in MT conditions 
(Fig. 1E).
ET culture conditions increased CD73 expression in RS-hAFSCs. CD105 (endoglin), a type I mem-
brane glycoprotein that plays an important role in the modulation of the TGFβ response, cellular migration and 
inflammation16, was not expressed in RS-hAFSCs cultured wholly in MT conditions. Conversely, cells expanded 
in ET conditions showed intermediate phenotype with highest proportions of positive cells when cultured wholly 
in ET conditions (Fig. 2A). CD73 (ecto-5′-nucleotidase), which plays a crucial role in the production of adeno-
sine, was homogeneously expressed in cells for the four culture conditions tested (Fig. 2A). However, comparative 
analysis of the mean fluorescence intensity (MFI) showed CD73 was more highly expressed on cells cultured 
wholly or subsequently in ET conditions (ET and MT-ET) in comparison to cells cultures wholly or subsequently 
in MT conditions (MT and ET-MT) (Fig. 2B). CD90 (Thy-1), which plays a role in T-cell activation, cell adhesion 
and migration, was expressed at similar levels under all conditions tested (Fig. 2A). The cells did not express 
CD45, a tyrosine phosphatase also known as the leukocyte common antigen (LCA) or the hematopoietic progen-
itor cell antigen CD34 in either conditions (Fig. 2A).
The human OCT4 (octamer-binding transcription factor 4) gene also known as POU5F1, generates 3 tran-
scripts (OCT4A, OCT4B and OCT4B1) by alternative splicing17. OCT4A, a key transcription factor involved 
in maintaining the pluripotency and self-renewal of ESCs and induced pluripotent stem cells (iPSCs), was not 
expressed in RS-hAFSCs, regardless of their culture conditions; although OCT4B, which does not sustain pluri-
potency and is expressed at low level in human somatic stem cells, tumour cells and adult tissues17, was expressed 
with a similar intensity in all conditions (Fig. 3A and B). SSEA4 (stage-specific embryonic antigen-4), a cell 
surface marker commonly used to identify pluripotent cells also expressed in the adult MSC population18, was 
expressed in all groups (Fig. 3A), with cells cultured wholly or subsequently in ET or MT-ET conditions showing 
higher expression (Fig. 3B). TRA-1-60 (T cell receptor alpha), a stem cell marker associated with pluripotency in 
human ESCs and iPSCs that is lost with differentiation, was absent in all groups (Fig. 3A). Signal transducer CD24 
(cluster of differentiation 24) is a cell surface adhesion molecule expressed in ESCs, neural stem cells and MSCs, 
where it modulates TGFβ signaling19. CD24 was expressed in all groups with a similar intensity (Fig. 3A and B).
ET culture conditions increased in vitro osteogenic differentiation efficiency of RS-hAFSCs. 
CD73-generated adenosine has been shown to promote osteoblast differentiation20–22 and SSEA4+ stem cell 
sub-populations exhibit enhanced osteogenic differentiation potential23. Therefore, we investigated the effect of 
culture conditions on osteogenic differentiation potential. RS-hAFSCs were cultured in ET or MT conditions for 
10 passages, detached and reseeded as single cells onto uncoated plastic dishes in osteogenic medium for 3 weeks. 
Cells that were wholly or subsequently cultured in ET conditions (ET or MT-ET) produced greater amounts of 
calcium (Fig. 4A) and showed higher levels of expression for the osteogenic genes COL1A, COL1A2, OC and OP 
(Fig. 4B). These results indicated that ET culture conditions are associated with higher levels of CD73 and a 4.4 
time increase in osteogenic differentiation efficiency.
ET culture condition enhanced osteogenic differentiation efficiency of RS-hAFSCs via CD73 
expression. To test whether CD73 directly modulated osteogenic differentiation potency of RS-hAFSCs, the 
osteogenic medium was supplemented daily with the CD73 inhibitor adenosine 5′-(α,β-methylene) diphosphate 
(CD73-i). As extracellular adenosine is generated by the dephosphorylation of adenosine triphosphate (ATP) by 
CD73, we also tested whether supplementation of the osteogenic medium with adenosine would enhance the 
osteogenic differentiation efficiency of RS-hAFSCs.
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Figure 1. Characterization of human round-shaped amniotic fluid stem cells (RS-hAFSCs) cultivated in MT 
and ET culture conditions. (A) Experimental design showing the different culture conditions of RS-hAFSCs, split 
into four experimental groups. Two groups of cells were cultured from the time of isolation until passage 10, one 
group in mesenchyme type (MT) culture conditions (on uncoated plastic dishes in DMEM supplemented with 
10% FBS) and the other in embryonic type (ET) culture conditions (on Matrigel-coated plastic dishes in Nutristem 
media). The remaining two groups were cultured in either MT or ET conditions until passage 5, when the culture 
conditions were switched to ET conditions in one group (MT-ET) and MT conditions in the other group (ET-
MT). The cells were analysed at passage 10. (B) Phase contrast images of RS-hAFSCs showing the morphology of 
the cells maintained either in MT, ET, MT-ET or ET-MT conditions. (C) Relative size of RS-hAFSCs cultured in 
MT, MT-ET, ET or ET-MT culture conditions (mean value of 3 median values each calculated from 10,000 cells). 
Representative flow scatter showing differences in forward scatter (FSC) median. Data represent mean ± SEM. 
SEM: standard error of the mean. *P < 0.05. (D) Left hand graph: cumulative population doubling calculated 
over 20 days for 3 different hAFSC samples cultured in different conditions. Right hand graph: cumulative cell 
numbers were calculated over 144 hours in the four different experimental groups. Data represent mean ± SEM. 
***P < 0.001. (E) Alkaline phosphatase activity showing % area of positive stain and representative images for RS-
hAFSCs cultured in different culture conditions. Data represent mean ± SEM. ***P < 0.001.
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In all four groups, calcium deposition, visualized by alizarin red staining, was abrogated when the cells were 
treated with CD73 inhibitor, but increased when the medium was supplemented with adenosine (Fig. 4C). 
Analysis of the expression of the osteogenic genes collagen type I (COL1), osteopontin (OP) and osteocalcin (OC) 
confirmed that inhibition of CD73 prevented osteogenic differentiation of RS-hAFSCs, whilst adenosine supple-
mentation increased the expression of the late osteogenic markers COL1, OP and OC (Fig. 4D). Taken together, 
these results indicate that ET culture conditions increase the osteogenic differentiation efficiency of RS-hAFSCs 
by 150% by stimulating CD73-induced adenosine production.
Figure 2. Immunophenotype of RS-hAFSCs cultured under different conditions. (A) Flow cytometry to 
show levels of expression of CD105, CD73, CD90, CD45 and CD34. Isotype control in blue. (B) Relative mean 
fluorescence intensity (MFI) for the different groups (measured from 10,000 cells and using the same antibody 
concentration, experimental conditions and cytometer settings for all groups). Data represent mean ± SEM. 
SEM: standard error of the mean. **P < 0.01.
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TGFβ induced nuclear import of Smad2/3 and increased CD73 expression in RS-hAFSCs cul-
tured in MT conditions. CD73 expression and adenosine generation are up-regulated by the TGFβ-Smad2/3 
signaling pathway24 and the translocation of Smad2/3 from the cytoplasm to the nucleus is an indication of the 
activation of TGF-β signaling. Smad2/3 is localised in the cytoplasm of RS-hAFSCs cultured wholly or subse-
quently in MT conditions (MT and ET-MT) which express low levels of CD73 (Fig. 5A), but in the nucleus of 
cells cultured wholly or subsequently in ET conditions (ET and MT-ET) expressing high levels of CD73 (Fig. 5B). 
This suggests that CD73 is modulated by TGFβ in RS-hAFSC and that ET culture conditions may increase the 
osteogenic potency of the cells by stimulating CD73 expression. To test this hypothesis, we treated the cells cul-
tured in MT conditions with TGFβ and the cells cultured wholly or subsequently in ET conditions with a TGFβ 
inhibitor. We found that TGFβ treatment induced nuclear import of Smad2/3 (Fig. 5A) whilst TGFβ inhibitor 
Figure 3. Immunophenotype of RS-hAFSCs cultured in in different conditions. (A) Flow cytometry to show 
the expression of OCT4-A, OCT4-B, SSEA4, Tra1-60, and CD24. Isotype control in blue. (B) Relative mean 
fluorescence intensity (MFI) for the different groups (measured from 10,000 cells and using the same antibody 
concentration, experimental conditions and cytometer settings for all groups). Data represent mean ± SEM. 
SEM: standard error of the mean. **P < 0.01.
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treatment induced its nuclear export (Fig. 5B). We next confirmed that TGFβ-induced Smad2/3 nuclear import 
was associated with an increase in CD73 expression, whilst TGFβ inhibitor-induced Smad2/3 nuclear export was 
associated with a decrease in CD73 expression (Fig. 5C)
Figure 4. In vitro osteogenic differentiation of RS-hAFSCs. (A) The media of passage 10 RS-hAFSCs cultured 
in different conditions was replaced by osteogenic medium (OM) for 3 weeks. The cultures were subsequently 
stained with Alizarin red to visualize areas of calcium deposition. The graph on the right hand represents the 
staining intensity of alizarin red staining relative to MT condition. (B) qRT-PCR to show expression of the 
osteogenic genes COL1A1, COL1A2, OP and OC in the four groups. GAPDH was used as internal control. (C) 
Passage 10 cells were cultured in osteogenic media supplemented with either the CD73 inhibitor adenosine 
5′-(α,β-methylene) diphosphate (OM+CD73i) or with the CD73 downstream product adenosine (OM+ade) 
for 3 weeks and subsequently stained with Alizarin red. The bottom panel represents the staining intensity 
relative to all condition. (D) qRT-PCR for collagen type I (COLI), osteocalcin (OC) and osteopontin (OP), 
normalized by their expression in RS-hAFSCs cultured in MT conditions. GAPDH was used as internal 
control. Data represent mean ± SEM for 3 samples per group. SEM: standard error of the mean. *P < 0.001. 
(mean ± SEM).
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Figure 5. TGFβ signaling in RS-hAFSCs cultured in different conditions. Confocal immunofluorescence 
staining for SMAD2/3. Nuclei were stained with DAPI (blue). (A) RS-hAFSC cells were cultured in MT or 
ET-MT with and without (untreated) supplementation with TGFβ. (B) RS-hAFSC cells were cultured in ET or 
MT-ET with and without (untreated) supplementation with a TGFβ inhibitor (TGFβ-i). (C) Mean fluorescence 
intensity (MFI) for the different groups (measured from 10,000 cells and using the same CD73 antibody 
concentration, experimental conditions and cytometer settings for all groups). Data represent mean ± SEM. 
SEM: standard error of the mean. **P < 0.01.
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TGFβ treatment enhanced osteogenic differentiation efficiency of RS-hAFSC. Since cells 
expressing high levels of CD73 showed higher osteogenic differentiation potency and TGFβ treatment increased 
CD73 levels, we next investigated whether treatment of RS-hAFSCs with TGFβ would lead to an increase in 
osteogenic differentiation potential. We observed that treatment with TGFβ of RS-hAFSC after culture in MT 
conditions increased calcium deposition (Fig. 6A) and expression levels of the osteogenic genes COL1 and OC 
(Fig. 6B), whilst treatment with a TGFβ inhibitor of the cells cultured in ET conditions prevented osteogenic 
differentiation (Fig. 6A and B). Together, these data indicate that ET culture conditions increase the osteogenic 
differentiation efficiency of RS-hAFSCs via TGFβ-induced increase in CD73-mediated adenosine production.
Methods
Ethics statement. The healthy donors who provided mid-trimester amniotic fluid in this study gave 
written informed consent in accordance with the Declaration of Helsinski. The ethical approval given by the 
joint Research Ethics Committee of University College London (UCL) and UCL Hospital (Ethics of Human 
Research) approved amniotic fluid stem cell collection (REC 08/H0714/87), in compliance with UK national 
guidelines (Review of the Guidance on the Research Use of Fetuses and Fetal Material (1989), also known as the 
Polkinghorne Guidelines. London: Her Majesty’s Sationery Office, 1989:Cm762) for the collection of human fetal 
tissue for research.
Cell culture. Amniocentesis procedures were performed under sterile conditions for clinical reasons such 
as prenatal diagnosis, and surplus fluid was used for research purposes. All amniotic fluid samples had a normal 
karyotype. Human amniocytes (hAFSCs) were isolated from the amniotic fluid (AF) between 15 to 22 weeks of 
gestation (healthy pregnancy). Fresh samples were divided in two. The AF was then pelleted and resuspended as 
a single cell suspension either on uncoated plastic dishes in Dulbecco’s Modified Eagle’s Medium (DMEM-HG) 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Biosera), 2 mM L-Glutamine, 50 IU/ml peni-
cillin and 50 mg/ml streptomycin (Gibco-BRL) (defined as MT culture conditions); or on Matrigel (BD) coated 
dishes in ESC media, i.e. Nutristem XF/FF (Stemgent) (defined as ET culture conditions). After 7–14 days of 
culture, single colonies appeared, with clones of cells presenting either a round-shape or a spindle-shape mor-
phology. Non-adherent cells were removed by washing the cell culture with PBS. The colonies with ≥50 cells 
Figure 6. TGFβ-dependent modulation of RS-hAFSC osteogenic differentiation. (A) The media of passage 
16 RS-hAFSCs cultured in different conditions was replaced by osteogenic medium (OM) for 3 weeks. 
Alternatively, the media of passage 10 RS-hAFSCs cultured in MT or ET-MT conditions was supplemented 
with TGFβ for 10 days before being replaced by osteogenic medium (OM+TGFβ) for 3 weeks and the media 
of passage 10 RS-hAFSCs cultured in ET or MT-ET conditions was supplemented with a TGFβ inhibitor 
(OM+TGFβ-i) for 48 h before being replaced by osteogenic medium (OM) for 3 weeks. The cultures were 
subsequently stained with Alizarin red to visualize areas of calcium deposition. (B) qRT-PCR for the osteogenic 
genes collagen type I (COL) and osteoclacin (OC), normalized to their expression in RS-hAFSCs cultured under 
MT conditions. GAPDH was used as internal control.
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were trypsinised and collected as described by Roubelakis et al.4 (Supplementary Figure 1). The colonies of 
round-shape (RS) cells were pooled and resuspended in either MT or ET conditions. Alternatively, the cells were 
cultured in either MT or ET conditions over the first 5 passages, and were subsequently transferred to ET or MT 
conditions, respectively (MT-ET and ET-MT conditions). The cells were cultured for a further 5 passages. All 
cells were analysed at passage 10. The cells were maintained at 37 °C in a 5% CO2 incubator. Alkaline phosphatase 
staining was performed following the manufacturer’s protocol (Roche).
Growth kinetics. The growth rate of RS-hAFSCs was estimated by plating 20,000 cells per well in a 12-well 
tissue culture plate in triplicate (3 samples). Every 24 hours, the cells were detached and counted in a hemocy-
tometer using trypan blue exclusion of dead cells. To compare the cumulative population doublings of the cells 
cultured in different conditions, they were plated in triplicate at a concentration of 104 cells per cm2 in 10-cm2 
dishes and successively subcultured at the same density when subconfluent. This replating procedure was serially 
repeated over 20 days, and the cumulative population doublings were determined by counting the number of 
adherent cells at the start and end of each passage.
Flow cytometry. The cells were detached, dissociated into single cells using dispase (Sigma-Aldrich), and 
resuspended in fluorescence-activated cell sorting (FACS) buffer (phosphate-buffered saline PBS, 1% BSA; 5 × 105 
cells/100 μl FACS buffer). For cell-surface staining the cells were stained with primary antibodies CD73-PE (130-
095-182, Miltenyi), CD105-FITC (130-094-926, Miltenyi), CD90- PE-VIO770 (130-099-295, Miltenyi), CD45-PE 
(130-098-141, Miltenyi), CD34-FITC (130-098-139, Miltenyi), CD24-FITC (130-098-861, Miltenyi), SSEA4-PE 
(FAB1435P, R&D), and TRA1-60-PE (09-0009, Stemgent) for 1 hour at 4 °C. For intracellular FACS staining, i.e. 
OCT4-A (130-105-606, Miltenyi) and OCT4-B (IC1759P, R&D), the cells were washed once in FACS buffer, fixed 
for 10 min in 0.01% paraformaldehyde (PFA), washed twice with PBS, resuspended in permeabilization buffer 
(PBS, 1% Triton) and stained as describe above. Cells were then washed twice with PBS, resuspended in FACS 
buffer and analysed by FACScalibur flow cytometry (CyAn ADP, Beckman Coulter). Collected data were ana-
lyzed with the Flowjo v.10 software package (Treestar, Ashland, OR, USA). Negative control was immunoglobulin 
G (IgG) primary antibody-specific isotypes.
Confocal immunostaining. For confocal immunostaining, the cells were directly stained on coverslips 
placed in the cell culture dishes. The cells were fixed in 4% paraformaldehyde (PFA) (10 min) and permeablized in 
0.5% Triton X-100 in PBS (15 min). Cells were then rinsed in PBS, blocked (1 hour) with 5% normal goat serum, 
incubated (overnight, 4 °C) with primary antibody (smad2/3 1:200, Cell Signaling Technology) in blocking solu-
tion, washed in blocking solution, incubated (1 hour) with secondary antibody (goat anti rabbit igG A11008, 
Thermo Fisher) in blocking solution, rinsed in PBS and stained with DAPI before being mounted in VectaShield 
(Vector Labs). Images were collected on a confocal laser-scanning microscope (Zeiss LSM7100).
In vitro osteogenic differentiation. Cells were detached, counted and re-seeded in a 24-well plate 
(with 40,000 cells per well) in osteogenic medium consisting in DMEM supplemented with 10% FBS, 2 mM 
L-Glutamine, 50 IU/ml penicillin, 50 mg/ml streptomycin, 10−8 M dexamethasone, 10−3 M ascorbic acid, and 
10 mM beta-glycerophophate (all Sigma-Aldrich). Osteogenic medium was freshly prepared and replaced twice 
weekly for 21 days. To detect mineralized nodules, cell culture plates were fixed in 10% formalin-buffered saline 
for 1 hour, washed in PBS and stained for 10 min with a 1% solution of alizarin red. Plates were then washed in 
water and left to air dry. Staining intensity was quantified using Image J software
Chemical treatment. The CD73 inhibitor adenosine 5′-(α,β-methylene) diphosphate (200 uM, M3763 
Sigma-Aldrich), adenosine (10 uM, A9251 Sigma-Aldrich), TGF-β (5 ng/ml, T7039 Sigma Aldrich) and TGF-β 
inhibitor (1 uM, S4317 Sigma Aldrich) were added freshly to the culture media daily over 3 weeks.
Quantitative real time RT-PCR. Total RNA was extracted using RNeasy Mini Kit (Qiagen) and cDNA was 
synthetized using High Capacity cDNA Reverse Transcription Kits (Thermo Scientific), according to the man-
ufacturer’s instructions. The generated cDNA was amplified using the ABI StepOne Sequence Detector system 
(Applied Biosystems) and SYBR green. Samples were normalized against the internal control (GAPDH).
Statistical analysis. Comparisons between groups were made using one-way ANOVA followed by 
Bonferroni’s multiple comparison post hoc test. The p values < 0.05 were considered significant. These were cal-
culated using Prism-7(version 7.0b) graphing and statistical software (GraphPad, San Diego, CA, USA). Data 
were expressed as mean ± SEM (standard error of the mean).
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
Discussion
Multipotent hAFSCs represent a heterogeneous population of spindle-shaped and round-shaped stem cells4, 5. 
Despite presenting an intermediate phenotype between adult mesenchymal stem cells (MSCs) and embryonic 
stem cells (ESCs), SS- and RS-hAFSCs are routinely cultivated in conditions that support the adhesion and expan-
sion of multipotent somatic fetal and adult stem cells (MT culture conditions), i.e. on uncoated plastic dishes 
either in Chang medium, DMEM or α-MEM supplemented with various concentration of FBS3. Whilst hAFSCs 
proliferate and maintain a stable phenotype in MT culture conditions, little is known about the optimal require-
ment of these cells to maintain their original in vivo phenotype. We previously showed that maintenance of 
SS-hAFSCs in conditions designed to sustain the pluripotent and self-renewal phenotype of ESCs and induced 
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 6601  | DOI:10.1038/s41598-017-06780-1
pluripotent stem cells (iPSCs), supplemented with valproic acid, reverted the cells to an earlier state of stemness, 
as evidenced by increased growth kinetics, activation of pluripotency genes and broader differentiation poten-
tial10, 12. The cells did not acquire tumorigenicity under these conditions since they were unable to form terato-
mas upon subcutaneous infusion into immune-compromised mice10, 12. RS-hAFSCs, which are more abundant 
than their SS counterparts, have been described as slower-growing epithelial-like cells with lesser differentiation 
potential.
Here, we show that cultivating RS-hAFSCs in ET conditions (either from the time of isolation or after an ini-
tial period of expansion in MT conditions) modified the phenotype of the cells and promoted their stemness, as 
evidenced by reduced cell size, increased growth kinetics and higher expression of alkaline phosphatase, CD73, 
CD105 and SSEA4. Importantly, this translated into greater in vitro osteogenic differentiation efficiency. Analysis 
of the mechanisms mediating this effect revealed that osteogenic differentiation potency of the cells is promoted 
through TGFβ-induced activation of CD73-generated extracellular adenosine.
Active TGFβ, which is measured without the acidification step in ELISA, is present in Nutristem (2 ng/ml) but 
is not detectable in FBS and in DMEM used to culture the cells in MT conditions, and is not produced by the cells 
(data not shown), and latent TGFβ has no biological activity. The amniotic fluid contains nutrients and growth 
factors that regulate fetal growth and development, such as TGFβ25. Active TGFβ is found in humans during the 
late stage of gestation and accelerates the rate of healing of intestinal wounds by stimulating cell migration25. 
Therefore, the composition of the Nutristem, which includes TGFβ, may be closer to the composition of the 
human amniotic fluid and may therefore sustain, or contribute to the cells regaining a more primitive phenotype 
of the cells, whilst culture in MT conditions may induce the differentiation of the cells and reduce their differen-
tiation and self-renewal potential.
At the cellular level, TGFβ upregulates the cell surface protein expression levels of ecto-5′-nucleotidase 
(CD73) cell surface levels by activating the NT5E gene via the TGFβ-Smad2/3 pathway24. CD73 then dephos-
phorylates ATP to produce adenosine in the extracellular space26. Extracellular adenosine regulates the inflam-
matory response by suppressing pro-inflammatory cytokines and stimulating anti-inflammatory cytokines27. 
In bone, adenosine released locally regulates the differentiation and function of bone-forming osteoblasts and 
bone-resorbing osteoclasts28. Extracellular accumulation of adenosine results in the activation of adenosine 
receptors. There are four receptors, i.e. A1R, A2AR A2BR, and A3R. Under adenosine conditions, A1R is activated to 
induce osteoclast differentiation, but when adenosine levels are above physiological conditions, the other recep-
tors are activated, which inhibits osteoclast differentiation by decreasing IL1β and TNFα secretion29. In contrast, 
in osteoblasts, activation of A2AR increases osteoblast differentiation and bone formation by activating the expres-
sion of osteoblast-related genes28. Together, these data indicate that the presence of TGFβ in Nutristem promotes 
the in vitro osteogenic differentiation of RS-hAFSCs, providing a strategy to augment the osteogenic potential of 
the cells for the treatment of bone pathologies.
Our findings also highlight that the phenotype of RS-hAFSCs is reversible, since cells that have been pre-
viously expanded in MT culture conditions before being switched to ET conditions acquire similar osteogenic 
efficiency and growth kinetics as cells that have been isolated and expanded exclusively in ET conditions. These 
results underscore the ability of hAFSCs to revert to an earlier state of stemness using chemicals alone, in the 
absence of ectopic expression of foreign DNA or RNA. The plastic phenotype of hAFSCs has already been doc-
umented in SS-hAFSCs, which could be reverted to functional pluripotency by cultivating the cells in ET condi-
tions supplemented with the histone deacetylase inhibitor valproic acid10, 12, 30. Further studies will be needed to 
determine the broader effect of ET culture condition on hAFSCs phenotype.
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